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Background: We aim to develop a rat model of veno-arterial extracorporeal membrane oxygenation (VA-ECMO).
Methods: VA-ECMO was established in twelve Male Sprague-Dawley rats (250-350 g) through cannulation of the
right jugular vein for venous drainage and the right femoral artery for arterial reinfusion. Arterial blood pressure was
measured using a conductance catheter through cannulation of the left carotid artery. Heart rate was monitored by
electrocardiography and arterial blood gas parameters with a blood gas analyzer. The VA-ECMO circuit was tested
by subjecting the rats to hypoxic cardiac arrest with resuscitation using VA-ECMO. Both load-dependent and load-
independent measures of myocardial contractility were measured using pressure-volume loop analysis to confirm
restoration of myocardial function post-resuscitation.
Results: Following hypoxic cardiac arrest VA-ECMO provided sufficient oxygenation to support the circulation. The
haemodynamic and blood gas parameters were maintained at transition and during ECMO. All animals were
resuscitated, regained cardiac function and were able to be weaned off ECMO post-resuscitation.
Conclusion: We have established a safe, high-throughput, economical, functioning rat model of VA-ECMO.
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Extracorporeal Membrane Oxygenation (ECMO) is a type
of mechanical circulatory support that is used for resusci-
tation of patients with failing pulmonary and cardiac func-
tion [1]. However, no effective rodent models of ECMO
support following cardiac arrest currently exist to allow
evaluation of post-arrest myocardial function. We describe
a novel technique for instituting veno-arterial extracor-
poreal membrane oxygenation (VA-ECMO) in a rodent
for resuscitation following hypoxic cardiac arrest. This
method restores the native circulation allowing the oppor-
tunity to conduct further studies on the physiological and
molecular changes occurring in the myocardium during
and after cardiac arrest.* Correspondence: zaa2112@columbia.edu
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All animals received humane care in compliance with the
‘Principles of laboratory animal care’ formulated by the
National Society for Medical Research and the ‘Guide for
the care and use of laboratory animal resources’ published
by the US National Institute of Health (NIH publication
No. 85-23, revised 1996). The following studies were ap-
proved by the Columbia University Institutional Animal
Care and Use Committee (IACUC) under protocol AC-
AAAG6406 and conform to the Guide for the Care and
Use of Laboratory Animals published by the National In-
stitutes of Health.Animals
Twelve 250-350 g male Sprague-Dawley rats were originally
sourced from Charles River Laboratories for use in the ex-
periments. Rats were maintained in temperature-controlled
(20°C to 22°C) cages with a 12-hour light-dark cycle, and
received free access to sterilized water and standard rodent
chow (Rodent diet BK002P, B & K Ltd).This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ali et al. Journal of Translational Medicine 2014, 12:37 Page 2 of 6
http://www.translational-medicine.com/content/12/1/37Anesthesia and ventilation
Rats were anesthetized using 3-4% isoflurane in an in-
duction chamber and maintained at 1.5-2.5% through a
nosecone. Endotracheal intubation was undertaken with
a 14G cannula (Smiths Medical, London, UK).
Operative procedure
The operative procedure, including implantation of all
ECMO cannulae, was conducted in the live animal, prior to
the induced hypoxic cardiac arrest. The animal was posi-
tioned with the lower limbs closest to the operating surgeon.
Under visualization of a dissecting microscope an incision
was made in the right groin to access the femoral vessels.
The femoral artery was dissected free from the femoral vein,
and the femoral vein was cannulated for administration of
fluids and medication. One-hundred units of intravenous
heparin were administered for anticoagulation.
A median sternotomy was performed to allow direct
visualization of the heart for confirmation of cardiac arrest.
The sternum was divided with electrocautery taking cau-
tion to avoid the right and left internal thoracic arteries.
The chest was retracted open with a miniature Finochietto
retractor and the thymus removed with electrocautery to
facilitate visualization of the heart, lungs, and great vessels.
For ECMO inflow, one centimetre of femoral artery was
exposed from the inguinal ligament distally. A small
hemostatic clamp (Yasargil, Germany) was applied as
proximal as possible to occlude the femoral artery and the
distal end of the femoral artery ligated. A small arteriot-
omy was made in the femoral artery and a 24 G angiocath
connected to 4 mm tygon tubing primed with normal sa-
line (Figure 1D) was advanced into the femoral artery. The
cannula was secured with two 6.0 nylon ligatures. The
clamp previously placed on the femoral artery was re-
moved. In some animals a left ventricular venting catheter
was placed to prevent overdistention.
For ECMO outflow the right jugular vein was dissected
in the cervical region and a small hemostatic clamp ap-
plied proximally to occlude the jugular vein. The vessel
was then ligated and retracted as distal as possible above
the clavicle to allow for cannulation. A small venotomy
was made at the distal end of the jugular vein and a 20 G
angiocath cannula connected to 4.0 mm tygon tubing ad-
vanced into the vein. A ligature was loosely placed around
the jugular vein to secure the cannula and then the clamp
occluding the vessel was removed. The cannula was then
gently manipulated until it was positioned in the superior
vena cava (SVC) under direct visualization.
Haemodynamic monitoring
Continuous acquisition of haemodynamic data was used
to complement the procedure and allow for precise moni-
toring of arterial pressure before and after ECMO reperfu-
sion. The right common carotid artery was dissected inthe cervical region. The vessel was ligated as distally in the
neck as possible, and a small occlusive clamp (Yasargil,
Germany) was used to occlude the carotid artery proximal
to the site of intended cannulation. A Millar ultra mini-
ature pressure catheter was connected to a Millar-Ultra
PVS console for measurement of left ventricular pressure
over the course of the experiment. A small arteriotomy
was made in the carotid artery distal to the clamp and the
catheter was inserted. A 6.0 ligature was used to secure
the catheter within the vessel.Establishment of the extracorporeal membrane
oxygenation circuit
The equipment and our ECMO model are depicted in
Figure 1. A micro-peristaltic pump was utilized for propul-
sion within the circuit (Digital Reglo Pump, Ismatec, Ltd;
Figure 1A, 1E). This is a digital tubing pump with 8 rotors.
The pump is marketed for flows ranging from 0.002-
57 ml/min with rotor speeds ranging from 1.6 to 160 revo-
lutions per minute. The required prime volume for our
ECMO model is 8 ml normal saline. 4.0 mm tygon tubing
was inserted into a customized pump cassette (Ismatec,
Ltd) and the outflow tubing arm was connected to a cus-
tom miniature oxygenator device (Figure 1C, 1F). Heparin-
ized saline was used to prime the oxygenator and the
circuit tubing. The pump inflow tubing was connected to
the venous drainage cannula and the oxygenator was then
connected to the arterial infusion cannula (Figure 1D). Fi-
nally a 12 ml syringe was added into the circuit proximal
to the pump via a 3-way stopcock (Figure 1H) to act as a
reservoir for addition of fluid if necessary to support pump
flow, which can occur with changes in position of the ven-
ous cannula within the SVC. Arterial blood gases were
measured using an Epoc blood analysis device (Epocal Inc,
Ontario, Canada). The parameters of haemodynamics and
blood gas analysis were recorded at 3 time points: pre-
operatively (0 mins), post cardiac arrest (15 mins), post re-
suscitation (60 min). Additional blood gas analysis were
performed ad hoc post resuscitation to ensure correction
of metabolic acidosis.Statistics
Data were subjected to the Kolmogorov-Smirnov test to
determine distribution. Descriptive variables are pre-
sented as means ± SD and compared with the t-test.
When comparing multiple groups data was analysed by
analysis of variance with Bonferroni post-test for mul-
tiple comparison of parametric data. Estimations are
presented with 95% confidence intervals. Conventional
levels of significance (0.05) were applied throughout.
Statistical analysis was undertaken using SPSS for win-














Figure 1 VA-ECMO circuit. Roller pump (A), tygon tubing conduit with three-way stopcock and male-male connector (B), silicone membrane
oxygenator (C), 24 G femoral arterial cannula (D). Bottom: Ismatec roller pump (E), silicone membrane oxygenator (F), small animal ventilator (G),
reservoir (H), right femoral artery cannula (I), right internal jugular vein cannula (J), endotracheal tube (K), left ventricular venting catheter (L).
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Cardiac arrest
We conducted experiments to evaluate the cardiac func-
tion of the rat heart after post-circulatory arrest with
warm ischaemia and subsequent reperfusion. Once all
ECMO cannulae were successfully implanted, we in-
duced hypoxic cardiac arrest by clamping the trachea to
produce asphyxiation. Tracheal occlusion was followedby progressive hypotension and bradycardia leading to
pulseless electrical activity cardiac arrest. Following a period
of circulatory arrest with 15 minutes of warm ischaemia,
the animals were reperfused with normothermic oxygen-
ated blood using VA-ECMO (Figure 2A). We initiated flow
at the lowest pump setting (0.001 ml/min) and gradually
increased flow until the arterial perfusion pressure was ap-
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Figure 2 Haemodynamics and myocardial contractility pre and post VA-ECMO resuscitation of hypoxic cardiac arrest. Phases of the
experiment showing blood pressure changes during hypoxia, ischaemia, and VA-ECMO resuscitation (A). Pressure-volume loops pre-arrest (B)
and post VA-ECMO resuscitation (C) showing an impairment in the end-systolic pressure volume relationship (upper slope of the PV loops)
but preserved pre-load recruitable stroke work.
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flow rate required to maintain these parameters in each
animal, but in general, flow ranged from 5-6 ml/min. Re-
perfusion was followed by the development of ventricular
fibrillation and subsequently spontaneous cardioversion
into normal sinus rhythm at a mean of 7.3 ± 2.8 minutes.
Upon return of sinus rhythm, ECMO reperfusion re-
sulted in an increase of 24 ± 4.2 mmHg in the meanarterial pressure (mAP). The period of warm ischaemia
led to significant metabolic abnormalities (Table 1) in-
cluding severe acidosis (pH 7.0 ± 0.1) that were corrected
with bolus injections of 500 μL 8.4% sodium bicarbonate
assessed by repeat arterial blood gases. Administration
of 0.1 ml of 10 mg/mL phenylephrine augmented mAP,
accelerating correction of acidosis that further increased
mAP to 52 ± 6.3 mmHg. As the mAP improved, the
Table 1 Metabolic changes pre and post VA-ECMO
resuscitation of hypoxic cardiac arrest
Biochemical parameter Baseline Anoxia Resuscitation P
HCO3-, mmol/L (SD) 20.9 (0.8) 14.1 (2.2)* 19.6 (1.8) <0.001
pH, (SD) 7.49 (0.1) 6.99 (0.1)* 7.38 (0.1) <0.001
pCO2,, mmHg (SD) 23 (11) 105 (29)* 42 (8) <0.001
pO2,, mmHg (SD) 225 (37) 64 (17)* 270 (55) <0.001
Hb, g/dl (SD) 15.5 (1.2) 16.4 (1.1) 9.2 (2.1)* <0.001
HCT, % (SD) 47 (4) 50 (3) 31 (3)* <0.001
sO2, % (SD 96 (2) 48 (18)* 99 (3) <0.001
K+, mmol/l (SD) 3.7 (0.8)* 5.5 (1.0) 5.1 (1.2) <0.001
Ca+, mmol/l (SD) 2.5 (0.8) 2.4 (0.3) 2.2 (0.4) 0.73
Lactate, mmol/L (SD) 3.3 (0.5) 3.7 (1.1) 2.8 (0.9) 0.43
HCO3-: Bicarbonate; pCO2: partial pressure of CO2; pO2: partial pressure of O2;
Hb: Hemoglobin; HCT: Hematocrit; sO2; K+: Potassium; Ca+: Calcium. Continuous
data are presented as mean with 95% confidential intervals (95% CI) or as median
with interquartile ranges (IQR 25-75). *Bonferroni’s Multiple Comparison Test.
Table 2 Measures of myocardial contractility pre and post
VA-ECMO resuscitation of hypoxic cardiac arrest
Load independent measurements Baseline Post-arrest P
Ees (Emax), mmHg/μL (SD) 2.3 (0.8) 1.4 (0.9) 0.04
PRSW, mmHg (SD) 60 (22) 70 (30) 0.46
Load dependent measurements
dP/dt max, mmHg/s (SD) 5221 (826) 3196 (1045) <0.001
dP/dt min, mmHg/s (SD) −5141 (1176) −2162 (542) <0.001
Cardiac output, μl/min (SD) 25749 (13835) 27008 (6994) 0.92
Stroke volume, μl (SD) 95 (38) 147 (51) 0.11
Stroke work, mmHg/μl (SD) 7192 (2566) 7371 (3419) 0.9
Diastolic function
Tau Glantz, msec (SD) 11.5 (2.0) 17.7 (8.4) 0.07
EDPVR (SD) 0.03 (0.0) 0.04 (0.03) 0.42
Ees (Emax), end-systolic elastance (slope of the end-systolic relationship);
Preload recruitable stroke work; dP/dt max: Maximum rate of LV pressure
change during systole; dP/dt min: Minimum rate of LV pressure change during
systole; EDPVR: End diastolic pressure volume relationship. Continuous data
are presented as mean with 95% confidential intervals (95% CI) or as median
with interquartile ranges (IQR 25-75).
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anical ventilation/oxygenation restarted while continuing
ECMO support for another 30 minutes. After 30 mi-
nutes, VA-ECMO could be completely stopped and the
resuscitated heart was able to sustain the circulation in-
dependently in all animals and metabolic homeostasis
was achieved independent of further pharmacological
correction. No animals required more than one attempt
at weaning ECMO support to demonstrate adequate car-
diac function to maintain unsupported perfusion.Assessment of haemodynamic and contractile function
Using micro-conductance catheters we obtained pressure-
volume (PV) loops from the left ventricle (LV) of experi-
mental animals. Pre-cardiac arrest and post VA-ECMO
resuscitation data are presented in Table 2. Compared to
pre-arrest (Figure 2B), following resuscitation load inde-
pendent measures of contractility demonstrated a reduced
end-systolic pressure volume relationship and end-systolic
stiffness (Ees Emax), yet pre-load recruitable stroke work was
sustained (Figure 2C). Load dependent measurements de-
monstrated a significant worsening of dP/dt max and min
in the VA-ECMO resuscitated heart but no significant dif-
ference in cardiac output, stroke volume or stroke work.
Diastolic function assessed by Tau was also impaired in the
ECMO resuscitated heart (Table 2).Discussion
Well-functioning rat models of cardiopulmonary bypass
have been established, including recent examples that do
not require priming with blood [2]. While these models are
helpful, ECMO is fundamentally different than cardiopul-
monary bypass in its clinical applications. The full bypass
circuit is not applicable to the patient who needs long-termcardiopulmonary support. ECMO is applicable to a broad
range of clinical scenarios, including bedside cannulation
for support during instances of hypoxic cardiac arrest [3,4].
A rabbit model of ECMO has recently been described to
test these applications [5]. Similar to the rabbit model, rats
have a nearly identical anatomy to humans with the advan-
tage of being smaller, less expensive, and easier to handle
than larger animal models.
A small animal model for ECMO is necessary because it
provides an efficient, economical, and accurate model for
the study of physiologic changes during ECMO. The esti-
mated cost of equipping a laboratory with a basic micro-
surgical setup such as dissecting microscope, small animal
ventilator, and surgical instruments is approximately
$3000. The costs specifically related to the ECMO circuit
include micro-oxygenators ($250 each/4-6 uses), Tygon
tubing ($200), intravenous cannuale ($200) and the micro-
peristaltic pump ($2400). In our model, nearly all equip-
ment is reusable and the cost incurred per experiment is
largely related to the purchase and boarding costs of the
rat (Male Sprague-Dawley rat, $30, Charles River Labora-
tories, Cambridge, MA; Boarding, approximately $20 for
acclimatization and prompt usage).
In our study, we developed the first rodent model of VA-
ECMO that was used for successful resuscitation following
an induced hypoxic cardiac arrest. After a 30-minute period
of supportive reperfusion, ECMO was weaned to assess the
ability of the resuscitated heart to support the circulation in-
dependently. Based on our results, we were able to show
that this model allows for return of cardiac function and
serves as the basis for subsequent investigation in areas such
as post-myocardial arrest depression, cardiogenic shock,
hemodynamic support and cardiovascular resuscitation.
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We have established a reliable and economical rat model
for VA-ECMO. Biochemical parameters and pressure-
volume relationships show that despite induced hypoxic
cardiac arrest, our VA-ECMO circuit was capable of re-
storing adequate circulation for return of full cardiac
function and perfusion.
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